Physician profile
Evangelos Sotiropoulos
NPI 1518257757
$1,875.85
in general payments reported to CMS, 2019-2025
18 companies · $97.64 in 2025
The $97.64 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $207 · 2021: $323 · 2022: $237 · 2023: $353 · 2024: $244 · 2025: $97.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $591.66 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $222.02 | 2019-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.47 | 2023-2025 | Xifaxan |
| Paratek Pharmaceuticals, INC. | $133.51 | 2022-2024 | Nuzyra |
| Medtronic, INC. | $117.64 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $112.57 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $99.67 | 2019 | |
| Silk Road Medical, INC. | $91.92 | 2019 | |
| Abiomed | $85.91 | 2019 | |
| Vifor Pharma, INC. | $63.39 | 2020-2021 | |
| Inari Medical, INC. | $46.72 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $36.02 | 2025 | Clottriever Bold Catheter |
| Gilead Sciences, INC. | $34.30 | 2023 | Veklury |
| Metacel Pharmaceuticals LLC | $24.91 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $23.13 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $18.88 | 2023 | Hillrom - Life 2000 Ventilation System |
| Novartis Pharmaceuticals Corporation | $15.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evangelos Sotiropoulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.